ENIA11

BIOLOGICAL2 trials

Sponsors

Mycenax Biotech Inc.

Conditions

Ankylosing SpondylitisRheumatoid Arthritis

Phase 3

A Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With Methotrexate Versus Methotrexate Alone in Patients With RA

Mycenax Biotech Inc.Rheumatoid Arthritis

Start: 2012-11-30End: 2019-12-31Updated: 2018-04-17

A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis

TerminatedNCT02685904

Mycenax Biotech Inc.Ankylosing Spondylitis

Start: 2016-09-06End: 2018-12-31Updated: 2019-03-12